Depreciation, Depletion and Amortization of Artiva Biotherapeutics, Inc. from 31 Dec 2023 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
Summary
Artiva Biotherapeutics, Inc. annual and quarterly Depreciation, Depletion and Amortization in USD history and change rate from 31 Dec 2023 to 31 Dec 2025.
  • Artiva Biotherapeutics, Inc. Depreciation, Depletion and Amortization for the quarter ending 31 Mar 2025 was $628,000, a 7% increase year-over-year.
  • Artiva Biotherapeutics, Inc. annual Depreciation, Depletion and Amortization for 2025 was $2,597,000, a 6.8% increase from 2024.
  • Artiva Biotherapeutics, Inc. annual Depreciation, Depletion and Amortization for 2024 was $2,431,000, a 7.3% increase from 2023.
Source SEC data
View on sec.gov
Depreciation, Depletion and Amortization, Annual (USD)
Depreciation, Depletion and Amortization, YoY Annual Change (%)
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Change (%)

Artiva Biotherapeutics, Inc. Annual Depreciation, Depletion and Amortization (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $2,597,000 +$166,000 +6.8% 01 Jan 2025 31 Dec 2025 10-K 10 Mar 2026 2025 FY
2024 $2,431,000 +$165,000 +7.3% 01 Jan 2024 31 Dec 2024 10-K 10 Mar 2026 2025 FY
2023 $2,266,000 01 Jan 2023 31 Dec 2023 10-K 24 Mar 2025 2024 FY

Artiva Biotherapeutics, Inc. Quarterly Depreciation, Depletion and Amortization (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $628,000 +$41,000 +7% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q1 2024 $587,000 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.